Thrombolytic Therapy in the Current ERA: Myocardial Infarction and Beyond

E-ISSN： 1873-4286|24|4|414-426

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.4, 2018-04, pp. : 414-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombolytic Therapy in Acute Myocardial Infarction

By Priglinger U. Huber K.

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 301-312

Adis International

Access to resources Recommend Favorite

Utilisation of Thrombolytic Therapy in Older Patients with Myocardial Infarction

By Woods K.L. Ketley D.

Drugs & Aging, Vol. 13, Iss. 6, 1998-12 ,pp. : 435-441

Adis International

Access to resources Recommend Favorite

Guidelines to Reducing Delays in Administration of Thrombolytic Therapy in Acute Myocardial Infarction

By Williams W.L.

Drugs, Vol. 55, Iss. 5, 1998-05 ,pp. : 689-698

Adis International

Access to resources Recommend Favorite

Mortality in patients with acute myocardial infarction who receive thrombolytic therapy is not related to the number of thrombolytic interventions performed in a hospital

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East

By Al-Zakwani Ibrahim

International Journal of Clinical Pharmacy, Vol. 34, Iss. 3, 2012-06 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite